Skip Navigation

JNCI Journal of the National Cancer Institute 2005 97(13):956-957; doi:10.1093/jnci/dji200
This Article
Right arrow Extract Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Request Permissions
Google Scholar
Right arrow Search for Related Content
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© 2005 Oxford University Press

NEWS

Awards, Appointments, Announcements

{blacksquare} Andrew Raubitschek, M.D., director of radioimmunotherapy, will serve as chair of the new Division of Cancer Immunotherapeutics and Tumor Immunology at City of Hope Cancer Center in Duarte, Calif. Michael C.V. Jensen, M.D., director of pediatric neuro-oncology, was named vice chair of the division.

{blacksquare} Marcel R. van den Brink, M.D., Ph.D., has been named chief of the Bone Marrow Transplant Service at Memorial Sloan-Kettering Cancer Center in New York.

{blacksquare} Richard J. O'Reilly, M.D., chairman of the Department of Pediatrics and Chief of the Pediatric Bone Marrow Transplant Service at Memorial Sloan-Kettering Cancer Center in New York, received the Lifetime Achievement Award from the American Society for Blood and Marrow Transplantation.

{blacksquare} Four cancer researchers have been selected as members of the National Academy of Sciences: Carolyn R. Bertozzi, Ph.D., professor of chemistry and molecular and cell biology, University of California, Berkeley; Susan Band Horwitz, Ph.D., Rose C. Falkenstein Chair in Cancer Research and associate director for drug development, Albert Einstein Cancer Center, New York; Mary-Claire King, Ph.D., American Cancer Society Research Professor, departments of medicine and genome sciences, University of Washington, Seattle; and Craig B. Thompson, M.D., scientific director, Abramson Family Cancer Research Institute, University of Pennsylvania, Philadelphia.

{blacksquare} Ed Seto, Ph.D., of the H. Lee Moffitt Cancer Center and Research Institute in Tampa, Fla., has been appointed the new Program Leader for Molecular Oncology. Richard Jove, Ph.D., held this position previously and is relocating to the City of Hope Cancer Center in Duarte, Calif.

{blacksquare} Jack D. Griffith, Ph.D., Kenan Distinguished Professor of microbiology and immunology at the University of North Carolina at Chapel Hill School of Medicine and member of the UNC Lineberger Comprehensive Cancer Center, has been elected a fellow of the American Academy of Arts and Sciences.

{blacksquare} The Association of American Physicians has announced that Dana-Farber Cancer Institute President Emeritus David G. Nathan, M.D., will receive the George M. Kober Medal in April 2006. The award recognizes physicians acknowledged as leaders in internal medicine.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?



This Article
Right arrow Extract Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Request Permissions
Google Scholar
Right arrow Search for Related Content
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?